Latest News
Events
Download
the brochure
of the Curetis Unyvero Solution.
Investor & Funds
A solid financial foundation
In two closings during 2011 Curetis raised more than 14 million Euros additional capital and has expanded its series A round to a total of EUR 34.1 million. This brings the total equity capital raised to date to EUR 36.6 million.
Curetis is financed by an international consortium, composed of aeris CAPITAL, LSP (Life Science Partners), BioMedPartners, CD-Venture, Forbion Capital Partners and Roche Venture Fund as well as the ERP-Startfonds of the KfW Bankengruppe.
Public Funding
In 2009 a joint R&D project of University Hospital Tübingen, the Natural and Medical Sciences Institute, Reutlingen, Germany, and Curetis AG received a two-year grant of over € 500,000 to develop effective tools to diagnose infections. The funding is part of the the ZIM program (Zentrales Innovationsprogramm Mittelstand – the central innovations program for medium-sized enterprises) of the German Federal Ministry of Economics and Technology (BMWi).
read more
Curetis has used the funding to develop the Curetis platform solution for diagnosing hospital acquired infections.
For five years, beginning in July 2008, the ZIM program provides funding opportunities for individual, collaborative and networked projects for small and medium sized companies striving for innovation. It forms the basis of the BMWi's technology support program and is aimed at reducing the technical and financial risks of R&D projects. It focuses on the quick commercialization of innovations.
In 2011, a joint project with collaborators Curetis AG, Polytechnic Schmalkalden (Germany) and Contexo GmbH (Winterbach, Germany) have obtained another € 500,000 of funding under the German ZIM Federal Innovation Grant Program. The joint R&D project focues on optimizing the mass production of consumables for innovative infectious disease diagnostics.
read more
For economic and efficient molecular diagnostic application disposables, plastics is the material of choice. Plastic materials that are employed must allow for complex three-dimensional structures, enabling the actuation and transportation of sample liquids and reagents, and at the same time allow for bio-compatible surfaces. Although it is possible to provide complex structures with them, currently available joining processes do not always allow for bio-compatible surfaces that can be produced economically. Therefore the ZIM grant supports the optimization of bio-compatible joining processes for fluidic systems in an enclosed disposable cartridge that can be reliably and cost effectively mass manufactured.
© Curetis AG 2012